Dare Bioscience Inc (NASDAQ:DARE) has a beta value of 1.11 and has seen 71.11 million shares traded in the last trading session. The company, currently valued at $27.35M, closed the last trade at $3.09 per share which meant it gained $0.57 on the day or 22.86% during that session. The DARE stock price is -48.87% off its 52-week high price of $4.60 and 31.72% above the 52-week low of $2.11.
Dare Bioscience Inc (NASDAQ:DARE) trade information
Sporting 22.86% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the DARE stock price touched $3.09 or saw a rise of 66.38%. Year-to-date, Dare Bioscience Inc shares have moved -6.93%, while the 5-day performance has seen it change 28.75%. Over the past 30 days, the shares of Dare Bioscience Inc (NASDAQ:DARE) have changed -4.92%.
Wall Street analysts have a consensus price target for the stock at $12, which means that the shares’ value could jump 74.25% from current levels. The projected low price target is $12.0 while the price target rests at a high of $12.0. In that case, then, we find that the current price level is -288.35% off the targeted high while a plunge would see the stock gain -288.35% from current levels.
Dare Bioscience Inc (DARE) estimates and forecasts
The company’s shares have lost -4.92% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 47.17% over the past 5 years.
DARE Dividends
Dare Bioscience Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Dare Bioscience Inc (NASDAQ:DARE)’s Major holders
The top two institutional holders are VANGUARD GROUP INC with over 3.36 million shares worth more than $1.13 million. As of 2024-06-30, VANGUARD GROUP INC held 3.3271% of shares outstanding.
The other major institutional holder is GEODE CAPITAL MANAGEMENT, LLC, with the holding of over 1.01 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.37 million and represent 0.9972% of shares outstanding.
